# Bioequivalence Study of Bicalutamide 50 mg Tablet and Casodex 50 mg Tablet in Healthy Subjects Under Fasting Conditions

> **NCT01039233** · PHASE1 · COMPLETED · sponsor: **Kremers Urban Development Company** · enrollment: 60 (actual)

## Conditions studied

- Bioequivalency

## Interventions

- **DRUG:** Bicalutamide 50 mg Tablet vs Casodex® 50 mg Tablet

## Key facts

- **NCT ID:** NCT01039233
- **Lead sponsor:** Kremers Urban Development Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-05
- **Primary completion:** 2005-06
- **Final completion:** 2005-07
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2009-12-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01039233

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01039233, "Bioequivalence Study of Bicalutamide 50 mg Tablet and Casodex 50 mg Tablet in Healthy Subjects Under Fasting Conditions". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01039233. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*